# FDA 483 - Matheson Tri-Gas, Inc - December 09, 2022

Source: https://www.globalkeysolutions.net/records/483/matheson-tri-gas-inc/18491013-fac8-4b88-8469-9edc1ae5d1ab

> FDA 483 for Matheson Tri-Gas, Inc on December 09, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Matheson Tri-Gas, Inc
- Inspection Date: 2022-12-09
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West III
- Summary: An FDA inspection of Matheson Tri-Gas, Inc. in Dallas, TX, a medical gas manufacturer, revealed a significant lapse in quality control. The firm failed to conduct annual product reviews for all trans-filled drug products, including Oxygen, USP, Carbon Dioxide, USP, Nitrogen, NF, and Nitrous Oxide, USP. This indicates a failure to maintain records for evaluating product quality and identifying opportunities for continuous process improvement.

## Related Officers

- [Margaret M. Ames](https://www.globalkeysolutions.net/people/margaret-m-ames/210023c9-39ed-4360-8ed3-55507c039252)
- [investigator](https://www.globalkeysolutions.net/people/kevin-t-nguyen/5ae9d562-7e4f-4305-895a-4b39c35acd16)
- [Investigator](https://www.globalkeysolutions.net/people/shanna-n-purdy/7a677cf5-484f-4e9a-91b1-27398411ff32)

Company: https://www.globalkeysolutions.net/companies/matheson-tri-gas-inc/febe6b86-8b75-4750-b678-7d5e94c0f08b

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-west-iii/2cda09a5-06c4-433f-9df0-0d7903a6efab